{"url":"https://lda.senate.gov/api/v1/filings/910ec3bf-bb4e-4eea-b7bf-0e934b50fda3/","filing_uuid":"910ec3bf-bb4e-4eea-b7bf-0e934b50fda3","filing_type":"Q2","filing_type_display":"2nd Quarter - Report","filing_year":2015,"filing_period":"second_quarter","filing_period_display":"2nd Quarter (Apr 1 - June 30)","filing_document_url":"https://lda.senate.gov/filings/public/filing/910ec3bf-bb4e-4eea-b7bf-0e934b50fda3/print/","filing_document_content_type":"text/html","income":"20000.00","expenses":null,"expenses_method":null,"expenses_method_display":null,"posted_by_name":"TJ Hartten","dt_posted":"2015-07-16T10:40:10.050000-04:00","termination_date":null,"registrant_country":"United States of America","registrant_ppb_country":null,"registrant_address_1":"701 8th Street, NW","registrant_address_2":null,"registrant_different_address":false,"registrant_city":"Washington","registrant_state":"DC","registrant_zip":"20001","registrant":{"id":41454,"url":"https://lda.senate.gov/api/v1/registrants/41454/","house_registrant_id":30771,"name":"WILLIAMS AND JENSEN, PLLC","description":"Lobbying Law Firm","address_1":"1201 Pennsylvania Avenue, NW","address_2":"Suite 800","address_3":null,"address_4":null,"city":"Washington","state":"DC","state_display":"District of Columbia","zip":"20004","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"ISABELLA QUINN","contact_telephone":"+1 202-659-8201","dt_updated":"2026-04-17T15:06:36.274151-04:00"},"client":{"id":151544,"url":"https://lda.senate.gov/api/v1/clients/151544/","client_id":1006575,"name":"UNITED COMPOUNDING MANAGEMENT, LLC","general_description":"Compounding pharmacy network","client_government_entity":false,"client_self_select":null,"state":"MO","state_display":"Missouri","country":"US","country_display":"United States of America","ppb_state":"MO","ppb_state_display":"Missouri","ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2014-11-06"},"lobbying_activities":[{"general_issue_code":"DEF","general_issue_code_display":"Defense","description":"The compounded drug benefit under the TRICARE program.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":18077,"prefix":null,"prefix_display":null,"first_name":"GEORGE","nickname":null,"middle_name":null,"last_name":"OLSEN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":37173,"prefix":null,"prefix_display":null,"first_name":"KARINA","nickname":null,"middle_name":null,"last_name":"LYNCH","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":60889,"prefix":null,"prefix_display":null,"first_name":"SHANE","nickname":null,"middle_name":null,"last_name":"DOUCET","suffix":null,"suffix_display":null},"covered_position":"Legislative Assistant for Rep. Chris John","new":false}],"government_entities":[{"id":25,"name":"Defense, Dept of (DOD)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]}],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[]}